📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

The committee for advanced therapies' of the European Medicines Agency reflection paper on management of clinical risks deriving from insertional mutagenesis. (2013)

First Author: Aiuti A
Attributed to:  MICA: MRC Centre for Neuromuscular Diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1089/humc.2013.119

PubMed Identifier: 23862696

Publication URI: http://europepmc.org/abstract/MED/23862696

Type: Journal Article/Review

Volume: 24

Parent Publication: Human gene therapy. Clinical development

Issue: 2

ISSN: 2324-8637